Literature DB >> 2187818

Immunopathological response of C57BL/6 and C3H/HeN mice to Aspergillus fumigatus antigens.

V P Kurup1, H Choi, A Resnick, J Kalbfleisch, J N Fink.   

Abstract

C3H/HeN and C57BL/6 mice were exposed to culture filtrate (CF) and mycelial extracts (ME) of Aspergillus fumigatus (Af) intranasally. Animals received 6, 8 or 10 biweekly doses and were sacrificed 2 weeks after the last dose was administered. Specific antibodies against Af were detected in their sera by biotin-avidin-linked immunosorbent assay (BALISA). Antibodies against Af belonging to all isotypes showed an increase in both strains of mice. A progressive increase in IgG and IgA antibody isotypes against both CF and ME antigens was detected in C3H/HeN mice during the entire experimental period, whereas most antibody levels peaked after the 8th dose and remained steady or decreased slightly in the C57BL/6 strain. Lung lavage studies showed a relative decrease in the number of macrophages and an increase in the number of lymphocytes after the 6th and 8th instillation of Af antigens in both strains of mice. Histology of the lung demonstrated a progressive inflammatory reaction in C57BL/6 mice during the experimental period. On the other hand, the C3H/HeN mice showed a negligible inflammatory pulmonary reaction. The antibody responses and inflammatory changes detected in the lungs of mice exposed to Af antigens are comparable to allergic bronchopulmonary aspergillosis (ABPA) in humans and hence this model will be of value in understanding the disease mechanism in ABPA and related diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187818     DOI: 10.1159/000235106

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  7 in total

Review 1.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Aspergillus antigen-induced eosinophil differentiation in a murine model.

Authors:  P S Murali; G Dai; A Kumar; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 3.  Animal models of allergic bronchopulmonary aspergillosis.

Authors:  Viswanath P Kurup; Gabriele Grunig
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

4.  Role of antibiotics and fungal microbiota in driving pulmonary allergic responses.

Authors:  Mairi C Noverr; Rachael M Noggle; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis.

Authors:  B Chauhan; A p Knutsen; P S Hutcheson; R G Slavin; C J Bellone
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

6.  Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis.

Authors:  G Grünig; D B Corry; M W Leach; B W Seymour; V P Kurup; D M Rennick
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

7.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.